Richard Page, now chairman of the department of medicine at the University of Wisconsin School of Medicine and Public Health, co-authored the large, international study that led to Multaq?s approval in the U.S. by the FDA last year, a move that could mean millions of dollars in sales for Sanofi-Aventis.
Office of Strategic Communication